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Mechanisms of haptoglobin protection against
hemoglobin peroxidation triggered endothelial damage
CA Schaer1,6, JW Deuel2,6, AG Bittermann3, IG Rubio4, G Schoedon2, DR Spahn1, RA Wepf3, F Vallelian2 and DJ Schaer*,2,5
Extracellular hemoglobin (Hb) has been recognized as a disease trigger in hemolytic conditions such as sickle cell disease,
malaria, and blood transfusion. In vivo, many of the adverse effects of free Hb can be attenuated by the Hb scavenger acute-
phase protein haptoglobin (Hp). The primary physiologic disturbances that can be caused by free Hb are found within the
cardiovascular system and Hb-triggered oxidative toxicity toward the endothelium has been promoted as a potential mechanism.
The molecular mechanisms of this toxicity as well as of the protective activities of Hp are not yet clear. Within this study, we
systematically investigated the structural, biochemical, and cell biologic nature of Hb toxicity in an endothelial cell system under
peroxidative stress. We identified two principal mechanisms of oxidative Hb toxicity that are mediated by globin degradation
products and by modified lipoprotein species, respectively. The two damage pathways trigger diverse and discriminative
inflammatory and cytotoxic responses. Hp provides structural stabilization of Hb and shields Hb’s oxidative reactions with
lipoproteins, providing dramatic protection against both pathways of toxicity. By these mechanisms, Hp shifts Hb’s destructive
pseudo-peroxidative reaction to a potential anti-oxidative function during peroxidative stress.
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Extracellular hemoglobin (Hb) hasmultiple biological activities
that can initiate and exacerbate disease processes.1 In
acquired and genetic hemolytic anemias, malaria, massive
blood transfusions, and severe infections, the presence of
free Hb appears to cause endothelial dysfunction, vascular
damage, and inflammation.2 More-localized effects of extra-
cellular Hb are relevant during the initiation and propagation of
atherosclerosis and in the regulation of inflammation and
wound healing.3,4
During mild hemolysis, Hb and heme scavenger
plasma proteins attenuate the adverse effects of extracellular
Hb.1 Haptoglobin (Hp) binds extracellular Hb to form an
irreversible complex that can be cleared by CD163-
positive monocytes and macrophages.5,6,7 Preclinical
studies have suggested a strong therapeutic potential
for Hp infusion in conditions with enhanced intravascular
hemolysis.8,9 Within the Hb/Hp complex, the inherent
vasoactivity of free Hb remains controlled, its redox reactivity
is stabilized, and Hb itself is protected against oxidative
damage.8,10,11
On amolecular level, the pathophysiology of Hb is generally
explained by its side reactions.1 Among these reactions,
depletion of the vasodilator nitric oxide (NO) and its reaction
with hydrogen peroxide (H2O2) are the most extensively
studied. H2O2 is produced by nicotinamide adenine dinucleo-
tide phosphate oxidases at supra-physiological levels upon
tissue damage by resident tissue cells (i.e., epithelial cells)
and during the subsequent inflammatory reaction by invading
leukocytes.12,13,14 However, although NO depletion and
associated endothelial dysfunction is now an accepted
pathophysiologic model, a set of cohesive mechanistic
concepts that link the oxidative side reactions of Hb to
adverse cellular and physiologic responses is still lacking.
Specifically, gaps in our knowledge remain concerning the
mechanisms that link the primary biochemical processes (i.e.,
the reactions of Hb with H2O2) with the reaction intermediates,
final effectors, and pathways that ultimately determine
cellular- and tissue-level damage. Accordingly, the mechan-
isms by which Hp could protect against oxidative Hb toxicity
are not clear. The current theories causally relate oxidative Hb
toxicity and Hp protection to diverse mechanisms even in the
absence of strong biological evidence.11,15,16,17,18,19,20
In this study, we utilized a systematic approach to
characterize Hp-attenuated reaction species that could
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mediate ‘oxidative’ toxicity of Hb to endothelial cells. The toxic
species identified include primary globin denaturation pro-
ducts and secondary lipoprotein peroxidation products, both
of which result from the continuous reactions of Hb with
physiological levels of H2O2.
Our results suggest that the anti-oxidative function of Hp
against endothelium-directed Hb toxicity is based primarily on
two activities. First, Hp stabilizes the protein structure of Hb
itself, thus preventing unfolding and aggregation of the
protein, and second, Hp halts heme and/or radical transfer
fromHb to reactive lipoproteins. Importantly, this caging effect
of Hp allows the Hb/Hp complex to function as a protective
sink for reactive oxygen species within Hb- and H2O2-
exposed tissues.
Results
Hb degradation products are an Hp-attenuated mediator
of endothelial damage. We incubated human endothelial
cells with human Hb (Fe2þ , 2mg/ml) and a low level of the
H2O2-generating enzyme glucose oxidase (GOX; 2.5mU/ml)
to simulate the conditions of concurrent extracellular Hb
exposure and oxidative stress (Figure 1). Low activities of
GOX in cell culture medium have been found to mimic levels
of H2O2 produced by stimulated neutrophil granulocytes.
14
Electrical endothelial resistance was measured as a func-
tional surrogate marker of endothelial damage. Combined
treatment with human Hb and GOX resulted in a rapid
decrease in endothelial resistance that occurred within hours
of the onset of the incubation period. Figure 1a shows
representative experiments for human umbilical vein
endothelial cells (HUVECs) and human pulmonary artery
endothelial cells (HPAECs); comparable results were
obtained with human lung microvascular endothelial cells
(HLMVECs) and human lymphatic endothelial cells
(HLyECs) in preliminary studies (data not shown). This
decrease in endothelial electrical resistance was accompa-
nied by the redistribution of the adherens junction protein
b-catenin and ultrastructural evidence of intercellular gap
formation in regions with decreased b-catenin staining
(Figure 1b). In contrast, when applied alone, even prolonged
incubations with either human Hb or GOX did not induce any
measurable changes in cell function or morphology. The
GOX activity used in these studies has been shown to
generate steady-state H2O2 levels in the range of 5–20 mM in
cell culture, which is in a low supra-physiologic range
observed acutely after wounding.12,21,22 Gene array analysis
confirmed that the low level of H2O2 generated in this model
induced only minimal changes in overall gene expression
that were not indicative of oxidative stress or cell damage
(Supplementary Figure 1).
The human HbþGOX-induced damage in HPAEC
(Figure 1c) was completely prevented by the addition of
purified human Hp (2mg/ml). Identical protection was also
found for other endothelial cell types (HPAEC, HLMVEC, and
HLyEC; data not shown).
Our earlier studies suggested that Hb bound toHp in theHb/
Hp complex can still react with H2O2, but the structure of the
Hb/Hp complex remains protected from oxidative damage and
denaturation.23 In contrast, in the absence of Hp, free Hb is
extensively oxidized at specific amino-acid sites leading to
structural destabilization of the protein with subsequent
denaturation, covalent protein cross-linking, and aggrega-
tion.24,25,26 Therefore, we speculated that the toxicity that
occurs in our model in the absence of Hp may be induced by
such Hb denaturation and aggregation products. To test this
hypothesis, we probed our cell culture system with two types
of Hb that are more resistant to oxidative protein degradation
by H2O2. These proteins were (1) a-a-cross-linked human Hb
(aXLHb). This Hb is a tetrameric Hb, which is stabilized by
the chemical cross-linker bis(3,5-dibromosalicyl)fumarate
(DBBF), and (2) bovine Hb (bvHb), which is a dissociable
tetramer with an enhanced conformational stability because of
its specific amino-acid sequence. Aggregation that could
occur upon unfolding of the different Hbs as well as of the
Hb/Hp complex during H2O2 reactions can be monitored by
spectrophotometry. As shown in Figure 2a, aggregate
formation can be observed with native human Hb but not with
aXLHb, bvHb, or the Hb/Hp complex. In strong correlation with
the absent aggregate formation, the oxidation of the structu-
rally stabilized Hbs was not associated with endothelial
damage (Figure 2b). The generation of Hb denaturation
products with the unstable human Hb could also be observed
in cell culture by scanning electron microscopy (SEM;
Figure 2c). We found extensive aggregate endothelial cell
interactions with engulfment of the nanometer- to micrometer-
sized particles by HPAECs (Figure 2d). Therefore, we
assumed that one mechanism of oxidative Hb toxicity is
directly related to the appearance of these Hb denaturation/
aggregation products that have the ability to initiate
endothelial cell damage (mechanism 1 in Figure 7).
The intrinsic Hb oxidation pathway generates toxic
reaction products that are attenuated by Hp. To conclu-
sively dissect the biological impact of the different Hb
oxidation products, we biochemically characterized the H2O2
reactions of all evaluated types of Hb and correlated the
generation of different oxidation products with the observed
biological responses of endothelial cells. Under identical
conditions as in our cell culture experiments (i.e., 37 1C and
complete endothelial cell culture medium), Hb heme-iron
oxidation with production of HbFe3þ and HbFe4þ was
similar for human Hb, aXLHb, bvHb, and the Hb/Hp complex
(Figure 3a). Heme release was slightly reduced with bvHb
and aXLHb, but only the Hb/Hp complex completely
prevented heme transfer from ferric Hb to hemopexin
(Hpx; Figures 3b and c). EPR-detectable 5-(diethoxy-
phosphoryl)-5-methyl-1-pyrroline-N-oxide (DEPMPO) radicals
were highest with the Hb/Hp complex, which is compatible
with a radical-stabilizing function of Hp.11 Human Hb, aXLHb,
and bvHb all led to similar levels of free radical production
(Figure 3d).
In this first model, it is likely that the Hb degradation
products, which are unique for the H2O2 reaction with the
human Hb, are the toxic species. Generation of the primary
heme-iron oxidation products (Hb-Fe3þ and Hb-Fe4þ ),
DEPMPO-trappable radicals, and free heme are common
among all reactions that occurred in the toxic as well as in the
nontoxic conditions. These species could therefore be
excluded as the ultimate mediators of toxicity.
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The extrinsic Hb oxidation pathway generates toxic lipid
oxidation products in the absence of Hp. To evaluate the
role of Hb reactions with extrinsic (non-Hb) molecules, we
supplemented our cell culture model by adding human
plasma-derived low-density lipoprotein (LDL) as a potential
substrate of Hb’s peroxidative activity. The addition of
0.5mg/ml LDL to the Hb-H2O2 reaction led to a cytotoxic
endothelial response with loss of electric monolayer
resistance (Figures 4b and c). This endothelial damage
mechanism was independent of Hb’s intrinsic structural
stability and did occur with human Hb, bvHb (Figure 4b),
and aXLHb (Figure 4c). No changes in electrical resistance
and/or morphology were observed during incubation of
endothelial cells with LDL±GOX in the absence of Hb. The
Hb/Hp complex attenuated Hb-driven LDL peroxidation and,
accordingly, Hp significantly delayed the endothelial mono-
layer damage that was associated with Hb-driven LDL
oxidation (Figure 4c; mechanism 2 in Figure 7).
Inflammation versus cytotoxicity. Intrinsic and extrinsic
oxidative Hb reaction pathways trigger distinct
endothelial damage. Based on the presented experiments,
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Figure 1 Hb oxidation, endothelial damage, and Hp protection. (a) Endothelial monolayer electrical resistance during treatment with human Hb (huHb, 2 mg/ml), a low/
nontoxic level of GOX (2.5 mU/ml), or the combination of huHbþGOX. Only the combination of huHbþGOX resulted in a significant decline of endothelial resistance over
time. ECIS traces represent means±S.D. of four replicate measurements. (b) The decline of HPAEC monolayer resistance was morphologically associated with a
redistribution of the adherens junction protein b-catenin (red) in fluorescence light microscopy (blue¼DAPI-stained nuclei). Imaging of the same specimen region with a
correlative SEM revealed intercellular gap formation (arrow head) with intercellular space spanning filopodia in the regions with decreased b-catenin staining. The arrow
indicates a conglomerate of Hb aggregates. No changes were observed when cells were only treated with Hb or GOX alone (data not shown). The incubation time in these
experiments was 6 h. (c) b-Catenin (red) redistribution in HPAECs was completely prevented when Hp (2 mg/ml) was present during the combined huHbþGOX treatment in
confocal laser scanning microscopy images (original magnification  630)
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two principal oxidative Hb reaction pathways can be
discriminated. An intrinsic oxidation pathway generates Hb
degradation products, whereas an extrinsic oxidation path-
way generates secondary lipid oxidation products. Both of
them can eventually lead to endothelial damage and both are
attenuated by Hp (Figure 7). Further evidence for the
discriminative nature of these two mechanisms could be
provided if unique cellular responses could be defined that
are specifically triggered by these two reactions. Therefore,
we characterized the messenger ribonucleic acid (mRNA)
expression profile of HPAECs in response to the two toxic
reactions by gene array analysis (Figure 5).
Figure 5a summarizes the reaction products that are
generated during the different toxic and nontoxic incubation
conditions and which eventually could stimulate transcrip-
tional responses in endothelial cells. Figure 5b shows a
principal component analysis (PCA) of the global mRNA
transcriptome changes triggered by the different treatments.
The PCA shows that the individual experimental samples
cluster within three distinct groups. Within the first group
(multiple colors) we find the control samples, as well as the
samples that were exposed to the previously defined nontoxic
Hb reactions. Specifically, within this group we identified the
samples that were only treated with Hb (Fe2þ ) as well as the
samples treated with the structurally stable bvHbþGOX
where redox cycling (Fe3þ /Fe4þ formation) as well as heme
release and radical production (but not globin degradation or
LDL oxidation) do occur. These data confirm that in this model
radical generation, ferric and ferryl Hb formation and heme
release are not the immediate inducers of the adverse
endothelial response. In contrast, the transcriptome profile
of the samples treated with the unstable human HbþGOX
(green) and samples exposed to bvHbþ LDLþGOX (brown)
clearly separated from each other and from all other
conditions.
To extract meaningful gene signatures that may better
define the apparently dichotomous adverse cellular
responses, we have selected all genes that were differently
expressed in any of the five tested conditions. The level of
selection stringency was set at greater than twofold upregula-
tion compared with control cells at FDR 0.05 (ANOVA). The
2046 genes thatmet these inclusion criteria served as an input
data set for the hierarchical two-way clustering analysis
shown in Figure 5c. As expected from the PCA, the samples
treated with ‘nontoxic’ conditions do not separate from
each other and it is not reasonable to extract characteristic
gene clusters or expression patterns for any of these
treatments, underpinning the minimal impact of the ‘common’
Hb reaction products on the endothelium. However, the
samples treated with bvHbþ LDLþGOX and those treated
with human HbþGOX clustered in two distinct groups were
clearly discriminated from each other by non-overlapping
gene signatures (see also Supplementary Excel Table for
more detailed data).
A functional analysis of the exposure-specific gene clusters
was performed with a comparative Metacore (Thomson
Reuters, New York, NY, USA) network analysis. The top 10
significantly enriched functional networks for each condition
are shown in Figure 5d. The response of cells treated with
bvHbþ LDLþGOX (gene cluster A) is characterized by
upregulation of heat shock proteins (e.g., heat shock protein
70) and activating transcription factor 3 (ATF3), which is a
known stress-inducible transcription factor.27 In contrast, the
human Hb aggregates evoke a paramount inflammatory
response with the adhesion molecule E-Selectin (SELE) as
themost upregulated signature gene (gene cluster B; see also
Supplementary Excel Table and Supplementary Figure 3 for
more detailed data).
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Figure 2 Hb oxidative stability, aggregate formation, and endothelial damage.
(a) Aggregate formation during the reaction of H2O2 (GOX 2.5 mU/ml) with the
different types of Hb (2 mg/ml) was recorded by time-resolved spectrophotometry at
700 nm under identical conditions as in the ECIS experiment with HPAEC shown in (b).
At equal H2O2 exposure, endothelial barrier function was compromised in the
presence of huHb but not in the presence of the structure-stable aXLHb or bvHb.
The addition of Hp (2 mg/ml) to the huHbþGOX reaction (red line) completely
prevented aggregate formation and endothelial barrier breakdown (blue line).
(c) The aggregates/precipitates can be localized on HPAEC by SEM (images were
recorded after 5 h). No aggregates can be visualized in the presence of Hp.
(d) Internalization of the Hb aggregates (arrows) by the endothelial cells can be
observed on zoom-in cell surface views (insert) and in a 3D reconstruction of serial
sections recorded with a FIB-SEM instrument. The white color appearance of the Hb
precipitates on the front section of the 3D image is indicative of the high density of
these particles that allowed automatic recognition and reconstruction by the image
processing software (Imaris Software), which clearly show internalized particles as
well as particle aggregates on the surface of the cell
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The apparent dichotomy of the cellular responses to the Hb
aggregates and the oxidized LDL, respectively, can also
be illustrated by a morphological analysis of adherence
junction (b-catenin) and cytoskeleton (actin) morphology
(Supplementary Figure 2).
The shielded pseudoperoxidase activity of Hb within the
Hb/Hp complex can protect endothelial cells against
peroxidative damage. Formation of the Hb/Hp complex
does not change the pseudoperoxidase (H2O2-consuming)
activity of Hb. Therefore, as an ultimate effect, Hp protection
could imply that this pseudoperoxidase activity could
represent a novel antioxidant function of the complex.23,26,28
To test this hypothesis, we adjusted our cell culture system to
mimic conditions of toxic H2O2 exposure (Figure 6). The
amount of H2O2 generated in situ by 20mU/ml GOX (high
GOX) is estimated to produce H2O2 steady-state levels in
high supra-physiologic range (50–100 mM) and induced
endothelial cell damage.21 Specifically, redistribution/
disappearance of the adherens junction protein b-catenin
and a decrease in transendothelial resistance could be
observed within hours (Figures 6a and c). In accordance with
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concentrations of the individual Hb oxidation states. (b) Heme release and transfer to Hpx from ferric Hb. Serial spectra were recorded from a mixture of ferric Hb (12.5mM)
with a 10-fold molar excess of Hpx. The first spectrum is red (ferric Hb) and the last recorded spectrum is blue (heme-Hpx). The insert shows the reference spectra of ferric Hb
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our previous experiments, endothelial damage appeared to
even be amplified when free huHb was added to the H2O2-
generating system and, consequently, toxic denaturation
products were formed (Figure 6c). However, the gene
expression analysis shown in Figure 6b suggested that Hb
switches the cellular mechanism of H2O2-mediated damage
from oxidative stress to inflammation. In agreement with the
H2O2-consuming activity of Hb, the H2O2-associated gene
cluster (gene cluster A) was normalized when extracellular
Hb was present in the treatment. The top upregulated gene
within this H2O2 signature cluster is the stress-signaling
transcription factor ATF3 (Supplementary Excel file).27
In contrast, the new gene cluster that appeared when Hb
was added to the oxidative system represents inflammation
(gene cluster B). The Hb-mediated switch from oxidative stress
to inflammation could be confirmed by quantitative real-time
polymerase chain reaction (RT-PCR) as a clear switch of high
ATF-3- high SELE gene expression (Figure 6d).
Supplementary Figure 3 illustrates the validation of our
array gene expression data with TaqMan real-time PCR for 15
genes that represent the oxidative stress (a) and inflammatory
(b) gene clusters shown in Figures 6b. For all genes, we found
congruent expression patterns between gene array and PCR
analysis, with a strong overall correlation between the two
methods (Pearson r2¼ 0.85; Po0.0001).
The shielded Hb/Hp complex prevented both pathways of
endothelial damage and attenuated all associated gene
expression changes.
Discussion
In a standardized cell culture model of concurrent Hb
exposure and oxidative stress, we defined Hp-attenuated
mechanisms by which Hb oxidation could damage the
endothelium. Two primary mechanisms could be defined
(Figure 7). The first mechanism involves Hb denaturation
products that trigger a strong inflammatory response,
whereas the second mechanism involves a cytotoxic reaction
induced by oxidatively transformed bystander molecules
(i.e., LDL). Hp stabilizes the Hb structure (preventing
mechanism 1) and shields the environment fromHb-catalyzed
oxidation (preventing mechanism 2). These unique protective
functions of Hp indicate an unrecognized biological role of the
Hb/Hp complex. Within the complex, the pseudoperoxidase
activity of Hb is switched from a destructive to a protective
reaction, which may ultimately help to preserve cell integrity
during peroxidative stress.
Our in vitro model is conceptually based on a correlative
analysis of (1) diverse cellular responses upon in situ
oxidative reactions of different types of Hb and (2) common
and divergent structure and reaction properties of these types
of Hb in addition to the Hb/Hp complex.
When endothelial cells were exposed to human Hb in the
presence of a nontoxic concentration of GOX, we observed a
decrease in transendothelial resistance, a loss of adherens
junction organization, and subsequently, a robust inflamma-
tory response. This response was observed in experiments
with several endothelial cell types and was completely
prevented by the presence of Hp. In contrast to the
experiments with human Hb, inflammatory responses, and
cell damage were not observed when endothelial cells were
exposed to the same peroxidative conditions in the presence
of structure-stable Hbs. These results lead to the following
questions: (1) What are the differences between the ‘toxic’
and ‘nontoxic’ types of Hb that could explain such a divergent
biologic response? (2) Could this observation explain a
mechanism whereby Hp could act as a protective Hb-binding
protein?
The types of Hb in this study are very similar. Human Hb
and aXLHb have the exact same peptide sequence and
comparable quaternary structures and differ only in a defined
chemical cross-linker that provides enhanced structural
stability to aXLHb.10 BvHb is a dissociable tetramer with
enhanced protein stability to pro-oxidants because of differ-
ences in the amino-acid sequence that have accumulated
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ECIS instrument. (c) Hb-mediated LDL oxidation and protection by Hp. Left panel:
O2 consumption was measured with an O2 sensitive micro-electrode in stirred
reaction mixtures of LDL with huHb-Fe3þ (red), aXLHb-Fe3þ (dark violet), bvHb-
Fe3þ (black), or huHb-Fe3þ /Hp complex (blue). Right panel: the Hb/Hp complex
(blue line) delayed the breakdown of endothelial electrical resistance compared with
when aXLHb (dark violet) or bvHb (violet) were used in the reaction mixture with
LDLþGOX. The control treatment (black line) was LDLþGOX in the absence of
any Hb (LDL 0.5 mg/ml and Hbs 0.1 mg/ml). All ECIS traces represent mean±S.D.
values of four replicate measurements
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Figure 5 Gene expression analysis of endothelial cells exposed to Hb-catalyzed oxidative reactions. (a) Reaction components (¼ endothelial cell treatments) and the
proposed in situ reaction intermediates and end products. (b) HPAECs were exposed to the indicated components for 8 h. The global mRNA expression pattern was analyzed
by Agilent gene expression arrays. In the PCA, the global expression profile of each sample is represented as a ball that is color coded for its treatment condition.
(c) Hierarchical clustering analysis of all genes that were significantly changed from baseline expression by any treatment condition. Each column represents the color-coded
gene expression pattern of a single sample. Treatment conditions are indicated at the top of the graph. The treatment discriminative gene clusters that were used for functional
network analysis are indicated at the right border of the graph. (d) The treatment discriminative gene clusters A (LDL peroxidation) and B (Hb degradation) were analyzed with
Metacore software for the enrichment of functional gene networks. The 10 most significantly enriched networks are indicated
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during evolution. Our biochemical characterization confirmed
that all three types of Hb are heme oxidized at comparable
rates by H2O2, thus excluding the ferric (Fe
3þ ) and ferryl
(Fe4þ ) forms of Hb as the immediate cytotoxic species. Also,
DEPMPO-trappable radicals were generated at comparable
rates and are therefore unlikely to be a direct mediator of
0 10 20 30 40
0
toxicity toxicity protection
to
ta
l r
es
is
ta
nc
e
Hb Hb:Hp
high GOX + hu Hb + hu Hb:Hp
time (h)
Cluster C
high GOX + human Hb + human HbHp
Cluster B
Cluster A
treatment
- inflammation
metacore
networks
- chemotaxis
- apoptosis
- stress signalling
(ATF-3,c-Jun/c-Fos)
- apoptosis
(endoplasmatic
reticulum, stress)
u
p
do
wn
hu Hb
hu Hb:Hp
control
0
50
Hb HbHb:Hp Hb:Hp
high GOXhigh GOX
ATF3 mRNA SELE mRNA
fo
ld
 c
ha
ng
e
control control
2000
1500
1000
500
0
2000
1500
1000
500
2500150
100
H2O2 consumption
H2O2
Figure 6 The Hb/Hp complex is a protective sink for cytotoxic extracellular H2O2. High-dose H2O2-mediated endothelial cell toxicity was mimicked by treating confluent
HUVEC endothelial monolayers with 20 mU/ml GOX (high GOX). (a) b-Catenin (red) immunofluorescence of endothelial cells incubated with high GOX, high GOXþ huHb,
or high GOXþHb/Hp (blue¼DAPI-stained nuclei, original magnification  630). (b) Global gene expression changes observed after 8 h with the treatments indicated on the
top of the graph. The heat-map shows the result of a hierarchical clustering of the most significantly upregulated (red) and downregulated (blue) genes (compared with
untreated controls). While there appeared to be almost no significant gene expression changes after high GOXþHb/Hp treatment, distinct and mutually exclusive clusters of
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independent experiments)
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toxicity. We could also disqualify dissociated free heme as the
ultimate mediator of cellular damage in this system as it is
released from all types of Hb in the absence of Hp.
Presumably, free heme did not exceed the threshold for
toxicity in our model. In addition, the endothelial cells were
likely protected from heme-mediated cytotoxicity by the
presence of plasma proteins in the cell culture medium as
well as by a strong baseline heme oxygenase 1 (HO-1)
expression that was further enhanced during oxidative Hb
stress. Rather, the role of free heme in our model concerns its
ability to enhance oxidative modification of bystander mole-
cules (if present).1,29 In a previously published study, we also
demonstrated that similar patterns and quantities of primary
globin amino-acid oxidation end-products (i.e., formation of
cysteic acid at position bCys93) occurred during oxidation of
native human and aXLHb.30
Collectively, we can exclude the primary heme-oxidized Hb
species (ferric Hb3þ or ferryl Hb4þ ), free heme, Hb oxidation-
derived free radicals, and secondary globin amino oxidation
products as being the immediate pro-inflammatory and
cytotoxic compounds that emerge during Hb peroxidation.
Hb is prone to complex oxidation-driven structural mod-
ifications, such as loss of a-helical structure, covalent globin
cross-linking, polymerization, and aggregation.24,25 These Hb
polymers/aggregates were the only reaction products that we
found to occur with the toxic native human Hb but not with the
two structure-stable Hbs. Endothelial cells extensively inter-
acted with and internalized these degradation products before
intercellular gaps, inflammation, and overt cellular damage
could be observed. Therefore, as all the other considered
reaction intermediates were the same among the three types
of Hb, it is likely that these Hb degradation products triggered
the adverse endothelial response. A similar process may also
explain the toxicity of Hb that was oxidatively damaged by the
bolus addition of H2O2, as reported by the Soares group.
31
In our earlier work, we demonstrated biochemical evidence
that Hp can stabilize the protein structure of Hb and that this
stabilization is essential for the effective recognition of the
complex by themacrophageHb scavenger receptor CD163.23
The model presented in this paper allows us to now, for the
first time, relate this Hb-stabilizing activity of Hp to a strong
anti-oxidative protective function within a biological system.
In an extended model that contained extrinsic
reactive molecules that could be modified by Hb’s peroxida-
tive reactivity, we could confirm that Hb-catalyzed oxidative
reactions also generate toxic non-globin products. In this
model, the external ‘mediator molecule’ (LDL) bears the
primary impact of the free radical reactivity and is thereby
transformed into a toxic compound (i.e., oxLDL). This
mechanism of Hb toxicity is independent of globin stability
and is in agreement with numerous earlier studies that
explored the lipid-peroxidative properties of free heme and
Hb, particularly in the context of atherosclerosis.29,32,33 The
discriminating gene expression responses triggered by the Hb
degradation and LDL peroxidation products, respectively,
suggest that not only the extracellular reactions and toxic
species but also the cellular signaling pathways clearly differ
between these two principal mechanisms of Hb toxicity.
Hp was also capable of blocking Hb-driven LDL oxidation
and thereby being protective against this second (‘extrinsic’)
mechanism of Hb-driven endothelial damage. Therefore, the
cumulative protective activity of Hp is related to Hp’s ability to
stabilize the globin structure and to ‘shield’ transition of
oxidation equivalents from Hb to other molecules.11,33
In the absence of strong protective mechanisms, such as
Hp, oxidative side reactions of extracellular Hb could
ultimately link tissue destruction, bleeding, local hemolysis,
and oxidative stress to accelerated inflammation and tissue
damage. Our studies provide now the first experimental
evidence that Hp can act as a molecular switch, which alters
the peroxidative reaction of Hb away from pro-inflammatory
and cytotoxic toward a protective function.
Materials and Methods
Endothelial cell culture models. All primary human endothelial cells and
the respective cell culture media were from Lonza (Basel, Switzerland). Cells were
cultured for a maximum of six passages. The following types of Hb were used
throughout the studies: (1) stroma-free human Hb (HbA0, huHb), which was
catalase depleted by DAEA chromatography. (2) Catalase-free ultrapure bvHb.
(3) DBBFaXLHb, both of which were provided by Dr. Abdu Alayash, FDA.
Hb/H2O2 experiments were performed with either 2.5 mU/ml (low GOX activity) or
20 mU/ml GOX (high GOX activity; from Sigma Chemical Co., St. Louis, MO, USA)
as indicated. Hb was used at 2 mg/ml (ferrous Hb) and glucose was used at 4 g/l.
All experiments were performed in complete culture medium (i.e., containing 2% fetal
calf serum and without phenol red). Electrical resistance of the endothelial cell
monolayers was measured in real time with an electric cell–substrate impedance
sensing (ECIS) Z Theta instrument (ibidi GmbH, Planegg/Martinsried, Germany) that
used eight-well disposable electrode arrays (8W10þ ). ECIS software version 1.2.52
was used to operate the instrument and for the subsequent data modeling and analysis.
Analysis of Hb oxidation and radical production during GOX
reactions. Spectral analysis of Hb oxidation by GOX-derived H2O2 was
performed with a Cary 60 UV-VIS Spectrophotometer (Agilent Technologies,
Basel, Switzerland). The reactions were monitored in complete endothelial cell
oxidized LDL
Hb degradation products
H2O2 consumption
Hp(radical shielding and
heme retention)
endothelial damage endothelial protection
Hp
radical
Hb(Fe3+) Hb(Fe4+)
secondary radical reactions
(Hb structural stabilization)
> mechanism 1: intrinsic oxidation pathway
endothelial damage (inflammation)
> mechanism 2: extrinsic oxidation pathway
heme release
Hb + H2O2
Figure 7 Schematic summary of Hb-catalyzed oxidative endothelial damage
and protection by Hp. Graphical illustration of the principal Hb toxicity and Hp
protection pathways described in this study. We propose that Hp protects against
peroxidative Hb toxicity by stabilizing the Hb structure (mechanism 1) and by
shielding extrinsic molecules against Hb/heme-mediated peroxidative damage
(mechanism 2)
Mechanisms of endothelial protection by haptoglobin
CA Schaer et al
1577
Cell Death and Differentiation
culture medium under conditions identical to those of the cell culture itself (37 1C).
Full spectra were recorded every 3 min and deconvoluted to calculate the
concentrations of the different reaction species.34 For the evaluation of aggregate
formation, the reactions were continuously measured at 700 nm. For electron
paramagnetic resonance (EPR) spin-trapping experiments, the same reactions
were performed in the presence of the spin trap DEPMPO (10 mM). During the
reaction, samples were measured sequentially in a Bruker ElexSys E500
@9.6 GHz X-band cw spectrometer (Bruker BioSpin AG, Faellanden, Switzerand).
Hb-Hpx heme transfer. MetHb (Fe3þ ) of the indicated Hbs was incubated
(10mM in phosphate-buffered saline (PBS) pH 7.4) with a twofold molar excess of
Hpx (from Athens Research and Technology, Inc., Athens, GA, USA). Serial UV-
VIS spectra were recorded with a Cary 60 UV-VIS Spectrophotometer (Agilent
Technologies) and deconvoluted to follow the transition of metHb to heme-Hpx
spectra.
LDL peroxidation assay. Human plasma-derived LDL was a kind gift of
Dr. Lucia Rohrer, Institute of Clinical Chemistry, University Hospital of Zurich,
Zurich, Switzerland. The oxidation of LDL (0.1 mg/ml in PBS, pH 7.4) was
measured in a closed, stirred microrespiration system with a Clark-type oxygen
electrode (Unisense, Aarhus, Denmark) at 37 1C after the injection of Hb in the
Fe3þ form (final Hb concentration was 10mM heme).
Quantitative real-time RT-PCR. RT-PCR has been performed as
described.35 Sequence-specific primers were as follows: HO-1 fwd
50-AGGGTGATAGAAGAGGCCAAGACT-30 and rev 50-TTCCACCGGACAAAGTT
CATGGC-30; ATF3 fwd 50-CAAGTGCATCTTTGCCTCAA-30 and rev 50-CCACCC
GAGGTACAGACACT-30, SELE fwd 50-AGCCCAGAGCCTTCAGTGTA-30 and rev
50-AACTGGGATTTGCTGTGTCC-30. Relative mRNA levels were calculated by the
7500 Fast System Sequence Detection Software Version 1.4 (Applied Biosystems,
Rotkreuz, Switzerland) after normalization of each experimental sample to HPRT
levels. The confirmation PCR experiments shown in Supplementary Figure 3 were
performed with predesigned TaqMan Gene Expression Assays (Life Technologies,
Basel, Switzerland). Probe set information can be obtained from the suppliers
webpage using the IDs provided in the table (www.invitrogen.com).
Gene expression microarray experiments and data analysis.
After washing and lysing the cells with buffer RLT, total RNA was isolated using
the RNeasy Mini Kit according to the manufacturer’s instructions, which included
an on-column DNA digestion step (RNase-Free DNase Set, Qiagen Hombrechtikon,
Switzerland). To ensure that only high-quality RNA (RNA integrity number47.0)
was used for gene expression analysis, each RNA sample was checked on a RNA
Nanochip with a Bioanalyzer 2100 (Agilent Technologies). RNA was quantified
spectrophotometrically with a NanoDrop ND-1000 spectrophotometer (Nanodrop
Technologies, Wilmington, DE, USA). Fluorescently labeled cRNA was generated
from 500 ng total RNA with the Quick Amp Labeling Kit (Agilent Technologies)
according to the manufacturer’s protocol, and differential gene expression profiling
was performed by competitive dual-color hybridization on Whole Human Genome
Oligo Microarrays (G4112F, 4 44 K, 60-mer, Agilent Technologies). Array slides
were XDR scanned and analyzed with Feature Extraction Software Version 10.7.3.1
(Agilent Technologies). Statistical analysis and visualization was performed with JMP
Genomics 5.0 (SAS Institute, Boeblingen, Germany). Full gene array data were
submitted to gene expression omnibus (GEO Accession #: GSE46471).
Confocal microscopy. For confocal immunofluorescence microscopy,
human endothelial cells were cultured on sterile, round 12-mm glass coverslips
(Hecht-Assistent, Sondheim, Germany) coated with rat-tail collagen (BD
Biosciences, San Jose, CA, USA) in 24-cluster wells. After treatment, cells were
washed with PBS, pH 7.4 (Sigma Chemical Co.), before fixation with 2.5%
paraformaldehyde in PBS for 15 min. Permeabilization was performed for 5 min
with 0.1% Triton X-100 (Sigma Chemical Co.) in PBS at room temperature. After
washing, nonspecific binding sites were blocked for 1 h at room temperature with
10% goat serum in PBS, supplemented with 1% bovine serum albumin (Sigma
Chemical Co.). Staining for b-catenin was performed with a polyclonal rabbit
antihuman b-catenin antibody (Cell Signaling Technology, Danvers, MA, USA)
overnight at 4 1C at a dilution of 1 : 150 in PBS with 1% goat serum and 0.1%
bovine serum albumin. A Cy3-labeled polyclonal sheep anti-rabbit antibody
(IgG fraction; Abcam, Cambridge, UK) was used as a secondary antibody at a
dilution of 1 : 50, and F-actin staining was performed with green fluorescently
(Alexa Fluor 488 dye) labeled Phalloidin (Invitrogen, Basel, Switzerland) at a dilution
of 1 : 80. Nuclear counterstaining was performed with 10 mcg/ml 4,6-diamidino-2-
phenylindole (DAPI; Sigma Chemical Co.). After three washes in PBS, coverslips
were mounted with ProLong Gold antifade reagent-mounting medium (Molecular
Probes, Invitrogen, Eugene, OR, USA). Samples were analyzed as z-stacks with a
Leica SP5 confocal laser-scanning microscopy system (Leica, Heidelberg,
Germany) with a HXL PL APO lambda blue 63.0 1.40 OIL UV objective.
Correlative light-electron microscopy (CLEM) and SEM analysis.
For CLEM analysis, endothelial cells were cultured as described above for
confocal microscopy on square-cut indium-tin-oxide (ITO) – coated 10 10 mm
glass coverslips marked for the shuttle and find solution integrated in the
AxioVision Software 4.8.2 (Carl Zeiss AG, Feldbach, Switzerland). Cells were fixed
with 2.5% paraformaldehyde in PBS for 15 min and directly stained (i.e., without a
permeabilization step) for b-catenin and F-actin as described for confocal
microscopy. Cells were kept in PBS after staining and during all fluorescence light
microscopy (FLM) imaging procedures with the coverslips placed in a sample
holder especially designed for CLEM. Widefield FLM images were recorded with
an Axio Imager M1 (Carl Zeiss AG) with a 20water emersion objective and an
AxioCam MRm. The samples were then prepared for electron microscopy and
transferred to a Zeiss Gemini 1530 FEG SEM (Gloor Instruments AG, Uster,
Switzerland). With the shuttle and find module of the AxioVision Software
(Carl Zeiss AG), regions of interest were relocated and SEM imaging was
performed. Overlays of the FLM and SEM pictures were performed with Adobe
Photoshop Software CS3 (Adobe Systems Incorporation, San Jose, CA, USA). In
some specimens, SEM analysis was performed in more detail and independent of
the correlative FLM images.
For SEM analysis, cell monolayers on ITO glass substrates were fixed in 2,5%
glutharaldehyde (Sigma Aldrich, Sigma-Aldrich Chemie GmbH, Buchs, Switzerland)
in PBS, washed in PBS, postfixed in 1% OsO4 (Electron Microscopy Sciences,
Hatfield, PA, USA), washed, incubated in 1% carbohydrazide (Sigma Aldrich) in
distilled water, washed, stained again in 1% OsO4, and washed. After dehydration
in a graded series of ethanol, the cell monolayers were plunged into liquid nitrogen
and freeze dried at  120 1C up to  80 1C overnight (in a freeze etching system
BAF060 from BalTEC AG, Balzers, Liechtenstein). Dried samples were warmed up
to room temperature, mounted to stubs with conductive carbon cement (Leit-C,
Neubauer Chemikalien, Munster, Germany), and sputter coated with 5 nm platinum
(BalTEC sputter coater: MED 010). Microscopy was performed in a Zeiss Gemini
1530 FEG in secondary electron mode at 5 kV.
For dual-beam microscopy (focused ion beam-SEM FIB/SEM), the cell
monolayers were treated as described for SEM but were soaked with Epon/
Araldite resin (compounds from Fluka analytical (Buchs, Switzerland) and Sigma
live sciences (Buchs, Switzerland)) after the dehydration. The resin was
polymerized for 2 days at 60 1C, samples were trimmed and mounted and sputter
coated as mentioned above. Cross-sections were performed in a Zeiss NVision 40
dual-beam microscope with gallium beam at 30 kV and 1.5 nA. Imaging of
consecutive sections were performed using back scatter electron signal at 2 kV with
an isotrope voxel size of 20 nm. Images were aligned in Fiji/ImageJ (http://fiji.sc) and
visualized in Imaris (Bitplain AG, Zurich, Switzerland).
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